Submit a term
Got a term you’d like us to add or one you’re unfamiliar with? We’re here to help! Share it with us, and let’s expand our glossary together!
Word of the week
Word of the Week was a fun and engaging campaign run by DATAMIND where team members selected a term from the DATAMIND glossary and shared insights based on their own experiences. These explanations were often delivered in creative and entertaining settings – ranging from horse riding to dog walks!
| Term | Category | Definition |
|---|---|---|
| Data Monitoring and Ethics Committee (DMEC) | Clinical Trials | This committee looks at both trial data and ethical issues. They ensure the trial is carried out ethically and the results are handled properly. |
| Clustering | Statistical Concepts | Definition:
Example:
Full Description: |
| Regression Anaysis | Statistical Concepts | Definition: Example: Full description: |
| Data Safety Monitoring Board (DSMB) | Clinical Trials | Another name for a committee like the Data Safety Monitoring Committee, which monitors participant safety and trial progress. |
| Data Safety Monitoring Committee (DSMC) | Clinical Trials | Like the Independent Data Monitoring Committee, this group focuses on keeping participants safe by reviewing trial data. They may also suggest changes to the trial if needed. |
| Independent Data Monitoring Committee (IDMC) | Clinical Trials | An independent group that checks trial data as it's collected. They make sure participants are safe and the trial is running as it should. If there are any serious concerns, they can suggest stopping the trial. |
| Trial Steering Committee (TSC) | Clinical Trials | A group that oversees the trial as a whole. They ensure it follows good clinical practices and protects the interests of participants. |
| Trial Management Group (TMG) | Clinical Trials | The team that handles the day-to-day running of a clinical trial. They manage schedules, budgets, and make sure the trial follows the approved plan. |
| Hawthorne Effect | Clinical Trials | When participants improve their behaviour or report better results simply because they know they are part of a study. For instance, if people in a study about a new drug feel they are being watched or measured, they may start feeling better or more motivated to follow the treatment, even if the drug itself isn't causing those changes. |
| Observer Effect | Clinical Trials | When people taking part in a study change their behaviour because they know they are being observed by researchers. For example, if people in a study know that their health habits are being monitored, they might be more careful about their diet or medication, which could affect the study results. |
| Copyright | UK Law and Rules | A legal right that protects creative works, such as written content, music, or computer software, ensuring only the creator can reproduce or distribute them. For example, research papers are usually protected by copyright, meaning others cannot copy or share them without permission. (Traditionally, journals owned the copyright to research papers. These days, the authors may keep the copyright and grant permissions so that everyone can read the research: "open access.") Copyright does not protect inventionsthose are covered by patents, which grant rights over new products, processes, or technologies.A legal right that protects creative works, like written content, music, or computer software, ensuring only the creator can reproduce or distribute them. For example, research papers are usually protected by copyright, meaning others cannot copy or share them without permission. (Traditionally, journals owned the copyright to research papers. These days, the authors may keep the copyright and grant permissions so that everyone can read the research: "open access".) |
| Bias | Health Research | An unfair influence or distortion that can affect the accuracy of study results or decisions. Bias can happen at various stages of research, including study design, data collection, or analysis. It can make results less reliable or applicable to certain groups of people. For example, if a study only includes young participants, it might create bias because the results may not apply to older people. This could lead to treatments or findings that are less effective or safe for older populations. Bias can also occur in how questions are asked, how data is analysed, or even in how results are interpreted. Researchers work to minimise bias to ensure the study is fair and results are accurate for everyone involved. |
| Behavioural Outcome Measures | Clinical Trials | Changes in a person's actions, habits, or routines as a result of a treatment or intervention. Behavioural outcomes are often studied because they can directly impact health and well-being. Researchers use these outcomes to see how interventions encourage healthier behaviors and prevent disease. For example, in a weight-loss program, a behavioral outcome might be participants eating more fruits and vegetables or exercising regularly, both of which contribute to improved health over time. |
| Economic Outcome Measures | Clinical Trials | The financial costs or savings linked to a treatment or intervention. Economic outcomes are important for understanding how a treatment affects healthcare systems, patients, and society. Researchers consider not just the price of the treatment but also how it influences other costs, like hospital visits, medication use, or missed workdays. For example, if a new diabetes medication leads to fewer hospital visits and reduces long-term complications, this is a positive economic outcome, saving money for both patients and the healthcare system. |
| Surrogate Outcome Measures | Clinical Trials | Indirect results measured in research to predict a larger or more meaningful outcome. These are often used because they are easier, quicker, or less expensive to measure compared to the main outcome of interest. Surrogate outcome measures help researchers make early judgments about a treatment's potential effectiveness before long-term results are available. For example, in heart health studies, cholesterol levels are used as a surrogate outcome measure to predict the risk of heart attacks. While improving cholesterol levels may suggest a treatment could reduce heart attack risk, cholesterol is not a direct measure of heart attacks, but it serves as a useful early indicator. |
| Patient-Reported Outcomes | Clinical Trials | Feedback directly from patients about how they feel or function after a treatment. These outcomes provide insight into a patient's perspective, beyond just clinical measurements, and are often collected through specific, validated questionnaires and structured data. For example, a patient-reported outcome might be a survey response where a patient says their pain decreased and mobility improved after physical therapy. This helps researchers understand the real-life impact of treatments on patients' well-being. |
| Clinical Outcome Measures | Clinical Trials | Measurable changes in a patient's health caused by a treatment or intervention. Outcomes are key to evaluating how effective a treatment is and whether it improves health. For example, in cancer trials, improved survival rates or reduced tumour size are clinical outcomes, and the clinical outcome measures are the tests, scans, or assessments used to track these changes and determine how well a treatment works. |
| Nocebo effect | Clinical Trials | When a person experiences negative side effects because they believe a treatment will harm them, even if the treatment contains no active ingredients. The nocebo effect can influence the results of clinical trials, as it may make it harder to determine whether a treatment truly causes side effects.For example, in a study, someone taking a placebo (a non-active treatment) might report side effects like headaches simply because they expect the treatment to cause them. Understanding and accounting for placebo/nocebo effects helps researchers interpret study results more accurately. |
| Deliverable | Research Project | A specific product or result promised as part of a research or project plan. Deliverables are key milestones tracked during a study or project. For example, a deliverable in a clinical trial could be a final report, a new medical device, or a dataset for further research. |
| Economic factors | Health Services and Health Data | Financial or resource-related conditions that impact a person's health or life opportunities, often studied to address disparities. For example, economic factors like income may determine whether someone can afford high-quality food. |
| Social factors | Health Services and Health Data | Conditions in a person's environment that affect their well-being, such as education, family, and access to resources. These factors are often studied in research to understand health inequalities. For example, living in an area with good schools and parks might improve someone's well-being. |
| DNA | Health Research | DNA or deoxyribonucleic acid is a molecule, present in all our cells, that contains the genetic code that is unique to every individual. Think of this code as an instruction manual for making all the proteins that form our bodies and help them thrive. The information coded in DNA is hereditary, meaning that it passes from parent to child. DNA testing is often used in research to study genetic conditions or ancestry. See genes. |
| Genetic Conditions | Health Research | Conditions caused by changes in a person's DNA, which can be inherited from parents or occur spontaneously. These conditions often affect how the body grows or functions. For example, genetic conditions, like cystic fibrosis, are studied to understand how inherited traits impact health and to develop treatments. |
| TSC (Trial Steering Committee) | Clinical Trials | This group provides overall supervision for a clinical trial. It ensures the study is being conducted according to ethical and scientific guidelines and offers advice on major decisions. |
| TMG (Trial Management Group) | Clinical Trials | This committee is responsible for the day-to-day management and operations of a clinical trial. It includes members like the principal investigator, trial coordinators, and researchers. |
| SUSAR (Suspected Unexpected Serious Adverse Reaction) | Clinical Trials | A harmful reaction that is serious and also unexpected because it wasn't yet listed in the study's safety information. For example, if someone in a study testing a blood pressure medicine develops a rare heart condition not previously linked to the medicine, this would be a SUSAR. |
| SAR (Suspected Adverse Reaction) | Clinical Trials | A harmful reaction thought to be caused by the treatment being tested in the study. This is based on when the reaction happens and how it matches the effects of the treatment. For example, if a person in a study testing a new headache pill develops a rash soon after taking it, this might be a SAR. |
| SAE (Serious Adverse Event) | Clinical Trials | A serious medical issue that happens during a study, which could include death, a life-threatening condition, the need to stay in the hospital longer, or lasting health problems. These events are not always reactions to the treatment being studied and may be unrelated. For example, if someone taking part in a drug trial develops a severe allergic reaction that causes them to stop breathing, this would be an SAE. Similarly, hospitalisation due to an accident, like falling off a ladder, would also count as an SAE. |
| Effects | Clinical Trials | The changes or results that happen because of a treatment or action. In studies, researchers look at the effects to see if a treatment works. For example, if a person takes a new pain medicine, the effect could be that their pain gets better or that they feel sleepy. Researchers study both the positive and negative effects of a treatment to understand how it works and get a balanced understanding of its impact. |
| Control Group | Clinical Trials | A group in a study that does not receive the treatment being tested. Instead, they receive the current standard treatment. The control group is similar to the test group to avoid bias and allows researchers to compare results. This helps determine if improvements in the test group are due to the treatment or other factors. For example, in a study for a new allergy pill, the control group might receive the current standard allergy treatment, and researchers compare their results to the group taking the new pill. |
| Placebo Effect | Clinical Trials | When a person feels better or experiences improvements (like their pain has reduced or gone) because they believe they are getting a real treatment, even if they're getting a fake one (a placebo). This effect can also occur with real treatments, as part of the response might come from the belief that the treatment will work, rather than the treatment itself.For example, someone taking a sugar pill in a headache study might feel their pain go away, even though the pill doesn't have any medicine in it. This can happen because they expect the treatment to work, or because they would have got better anyway. See also nocebo effect. |
| Placebo | Clinical Trials | A treatment that looks real but doesn't have any active ingredients or effect. It's used in studies to compare with the actual treatment and see if the real one works better. Placebos can be used in medicine, therapy, or other types of treatments. For example, in a study for a new headache pill, some people might get a real pill, while others get a placebo (like a sugar pill) that doesn't actually treat headaches. A placebo is not a denial of treatment but rather a tool to help with blinding, ensuring fairness in the study. |
| Patent | Research Project | A legal right that protects a new invention, stopping others from making, using, or selling it without permission. For example, if researchers create a new algorithm to predict depression risk, they might be able to patent it to ensure that only they or approved users can use it. Unlike copyright, which protects creative works (including computer software), patents specifically protect inventions or innovations. |
| Outcomes | Research Project | In research or clinical trials, outcomes are the specific results or changes measured to understand the impact of a treatment or intervention. These might include clinical changes (like lower blood pressure), patient feedback (such as improved quality of life), or even cost savings for healthcare systems. Outcomes help determine if the treatment works and what effects it has on people's health and well-being. |
| Outputs | Research Project | Things produced during the lifetime of a project, which can be tangible (like reports, datasets, prototypes) or intangible (like new processes or collaborations). All deliverables are outputs, but not all outputs are necessarily deliverables. |
| Milestone | Research Project | A milestone is a key event or goal in a project that marks progress. In a research project, milestones might include getting ethical approval, recruiting participants, finishing testing, analysing data, or writing the final project report. Milestones often produce something specific, called a "deliverable," such as a policy report, new software, a research dataset, or a plan for a future clinical trial. |
| Foreground Intellectual Property | Research Project | New ideas, inventions, or creations that are developed during a project or research. For example, if a university team is working on a new type of medical device and they create a new technology during the project, that new technology would be their "foreground IP." It belongs to the team that developed it, and they can choose to protect it with patents or other legal rights. |
| Background Intellectual Property | Research Project | Intellectual property that already exists and is required for or used in a project. |
| Intellectual Property (IP) | Research Project | Creations of the mind, such as inventions, designs, symbols, and names, produced during a project that need to be managed. Intellectual property may be protected by copyright or patent law. IP includes both "background" IP (existing prior to the project) and "foreground" IP (created during the project). |
| NHS DigiTrials | Health Services and Health Data | A service that helps with clinical trials in the NHS by giving researchers secure access to specific health data. This data helps researchers find participants for trials, track how the trial is going, and check how well treatments work. For example, during the COVID-19 pandemic, NHS DigiTrials supported the RECOVERY trial by providing data that helped researchers quickly discover effective treatments for hospitalised patients. Researchers must go through a strict approval process and can only access the data they need, keeping patient information private and secure. |
| Secure Data Environment | Computing | A controlled, safe space for storing and analysing sensitive data. For example, a secure server where researchers work with confidential patient information. Also called a Trusted Research Environment. |
| Synthetic Data | Data in General | Artificially generated data used in research to protect privacy while testing systems or models. For example, creating fake patient data to train a new medical procedure. |
| Healthcare System Data | Clinical Trials | Information collected by healthcare services about patient care and outcomes, such as hospital visits, diagnoses, treatments, recovery rates, demographics, and medical history. This data can be used for clinical care, planning, or research to improve healthcare services. |
| Trials Oversight Committees | Clinical Trials | Groups that oversee clinical trials to ensure they are conducted safely and fairly. These include: Trial Management Group (TMG) Trial Steering Committee (TSC) Independent Data Monitoring Committee (IDMC) Data Safety Monitoring Committee (DSMC) Data Safety Monitoring Board (DSMB) Data Monitoring and Ethics Committee (DMEC) See individual definitions for more details. |
| Allocated treatment | Clinical Trials | The specific treatment assigned to a participant in a clinical trial. For example, a participant may be assigned to receive either the new drug being tested or the standard treatment or a placebo. |
| Sponsor | Clinical Trials | The person or organisation that funds and oversees a research study. For example, a university or a pharmaceutical company sponsoring a clinical trial for a new medication. |
| Regulator | Clinical Trials | An organisation that makes sure drugs and medical treatments are safe and effective. The Medicines and Healthcare products Regulatory Agency (MHRA) is an example of an UK regulator. It checks that medicines, vaccines, and medical devices are safe and work well before people can use them. For instance, the MHRA approved the COVID-19 vaccines used in the UK. |
| Randomised/ Randomisation | Clinical Trials | Assigning participants to different groups by chance, to avoid bias. For example, randomly assigning patients to receive either a new drug or a placebo. |
| PPI (Patient and Public Involvement) / PPIE (Patient and Public Involvement and Engagement) | Clinical Trials | Involving patients and the public in the research process to ensure it meets their needs. For example, getting feedback from patients and carers to improve study design and relevance. |
| Phase (I/ II/ III/ IV) | Clinical Trials | Stages of clinical trials to test potential new treatments in people. For example, Phase I trials test a new drug's safety in a small group, while Phase III trials test its effectiveness and detailed safety in a larger group. A new drug would start at Phase I. If it "passes" a phase, it can progress to larger trials, and may ultimately become approved as a new medicine. |
| Preclinical research | Health Research | Research in the laboratory, not relating to the treatment of human or animal illness. For example, studying DNA in yeast to learn more about how cells work. |
| Clinical research | Health Research | Research on diseases or illnesses, such as in humans. For example, testing a new treatment for diabetes. |
| Patient Information Sheet/ Leaflet | Clinical Trials | A document that explains the details of a study to participants in simple language. For example, a leaflet that outlines what will happen in a clinical trial and what participants should expect. This is important so people can give informed consent. |
| Funding | Research Project | Money provided to support a research study. For example, a government grant that funds research on new medications. |
| Follow-up | Clinical Trials | Part of a study where researchers check in with participants later on to carry out specific measures outlined in the study protocol. This helps monitor health, track progress, and make changes if needed. For example, following up with patients after surgery to see how they are recovering. |
| Ethics Committee | Clinical Trials | A group that reviews and approves (or refuses) proposed research to ensure it is ethical and protects participants' rights. For example, an ethics committee evaluates a study's protocol before it starts. To make sure that the study will be carried out in a safe and appropriate manner. They provide a favourable or unfavourable opinion based on their review. |
| Consent Form | Clinical Trials | A document that participants sign to help show they understand a study and agree to participate. For example, a form that explains the risks and benefits of a clinical trial. It is given alongside or combined with an Information Sheet or Leaflet, which provides additional details about the study, such as its purpose, risks, and benefits. The Consent Form ensures that participants are fully informed and agree to take part voluntarily. |
| Adverse Event (including SAE, SAR and SUSAR) | Clinical Trials | Any medical problem that happens during a study, which may or may not be related to the treatment. For example, a participant might experience a fever or headache that isn't necessarily caused by the study drug. Adverse Reaction (AR): A harmful reaction or side effect that is caused by the treatment. For example, an allergic reaction during the trial. Serious Adverse Event (SAE): A medical problem that causes serious harm, like needing to go to the hospital, being life-threatening, causing long-term problems, or even death. This can happen whether or not it is related to the treatment. Serious Adverse Reaction (SAR): A serious medical problem that is specifically caused by the treatment. Suspected Unexpected Serious Adverse Reaction (SUSAR): A serious reaction caused by the treatment that was not expected based on what is already known about it. These must be reported right away to regulators. Not all medical problems (AEs or SAEs) during a study are caused by the treatment. Only reactions (ARs, SARs, or SUSARs) are directly linked to it. |
| Platform Trials | Clinical Trials | Trials that test multiple treatments in one main study, often for the same disease. Each participant is only given one treatment. For example, a cancer trial testing several new drugs against a standard treatment. |
| Adaptive Trials | Clinical Trials | Clinical trials that are designed to allow adjustments based on early results in a pre-specified way. For example, changing the dosage of a drug if early results show it is too strong or too weak. |
| Cluster Randomised Trials | Clinical Trials | Studies where groups of participants (called clusters), such as those from entire hospitals, are randomly assigned to the same treatment to prevent bias. For example, one hospital might try a new treatment while another uses standard care. |
| Stratification | Clinical Trials | Dividing study participants into different groups ("strata", meaning "layers") based on certain characteristics to ensure even distribution. For example, dividing participants by age to make sure all age groups are equally represented in a clinical trial. |
| Independent Monitoring System | Clinical Trials | A group that reviews a study to ensure it is conducted safely and ethically. For example, a group that monitors clinical trials to protect participants safety and rights. |
| Double-Blind Trial | Clinical Trials | A study where neither the participants nor the researchers know who is getting which treatment. This prevents bias and makes the results more reliable. In a double-blind drug trial, for instance, neither the patients nor the research team know who is receiving the real drug or a placebo. However, someone, typically a third-party coordinator, does know the treatment assignments to ensure proper blinding and analysis. |
| Masking (also called Blinding) | Clinical Trials | Keeping participants and sometimes researchers in a study from knowing which treatment is being given to prevent unfair results. For example, in a drug trial, participants might not know if they are getting the real medicine or a fake one (placebo). This helps avoid bias and makes the results more reliable. Who is kept unaware depends on the type of study. Not to be confused with protecting everyone from knowing the accumulating comparative results (i.e. keeping people blinded to the results). See also double blind trails |
| Tertiary care data | Health Services and Health Data | Information from highly specialised healthcare services, like inpatient eating disorder services. or a neurosurgery department. |
| Secondary care data | Health Services and Health Data | Information from specialist healthcare services, such as hospitals. For example, data from a psychiatric outpatient clinic or a mental health hospital admission. |
| Socioeconomic | Health Services and Health Data | Relating to social and/or economic factors. For example, socioeconomic factors can impact access to healthcare: someone with a lower income might struggle to afford healthcare, or face challenges like long or expensive travel to reach a doctor. |
| Phenotype data | Health Research | Information about an organism's traits, like height, eye color, or mental health. For example, phenotype data is used to study how certain traits are inherited or could be used to personalise treatments. |
| Measures | Health Research | In any study, we need to decide what we are measuring and how. For example, we might measure waist circumference to assess obesity or use a heart rate monitor to track fitness. These are the measures we are interested in, and it's important that everyone in the study uses the same methods to ensure consistent and unbiased results. |
| Linked Administrative Records | Data in General | Data combined from various sources, like healthcare and tax records, used for research. For example, combining health data with income information to study the effects of poverty on health. |
| Genes | Health Research | Units of DNA, arranged in different sequences, that determine traits and characteristics. For example, genes influence things like eye colour and risk for certain diseases passed from parent to child. |
| Epidemiology/ Epidemiological | Health Research | This is the study of how often diseases occur and why they affect different groups of people. It includes understanding the age at which diseases typically start, which populations are more likely to be affected, and whether certain diseases are becoming more common over time. This knowledge helps us understand who is most at risk and how diseases impact the population as well as plan action to manage them. For example, epidemiologists track infectious disease outbreaks to learn how to prevent diseases from spreading and allocate resources like vaccinations when needed, or mental health trends to understand what might be causing changes and what to do about it. |
| Electronic Health Records | Health Services and Health Data | Digital versions of patients' medical histories, including diagnoses and treatments. These digital versions allows healthcare staff to access patients' information when needed. |
| DNA samples | Health Research | Pieces of DNA collected from people, such as from their saliva or blood, for testing or research. For example, DNA samples can be used to check for genetic diseases or to trace ancestry. |
| Cognition | Health Research | The mental process of learning and understanding things, like thinking and remembering. Studying cognition helps us understand how people solve problems and learn new skills, and how this can go wrong. |
| Interoperability | Computing | The ability of different systems to work together and share information. For example, it allows different hospitals to access and exchange patient data safely and securely. |
| Protocol | Clinical Trials | A detailed plan or set of rules that explains how a study or experiment will happen. For example, in a clinical trial, the protocol might explain how participants are chosen, what treatments they will receive, and how results will be measured to ensure fairness and safety. |
| Membership Inference Attack | Computing | A privacy breach where someone finds out, using sophisticated methods, if your personal data was used to train a computer program. For example, they could discover that your health records were used in a program that predicts illnesses. This can expose private information that should stay confidential. |
| Bias Mitigation | Processes | Actions or methods to identify and reduce unfairness in decisions or systems. For example, imagine a computer program used to help with hiring decisions. If the program favors men over women because it was trained on biased data from past hiring practices, it could continue making unfair decisions. With bias mitigation, the program can be adjusted to ignore gender and focus only on candidates' skills and experience, making the process fairer for everyone These methods ensure fairness throughout and help prevent discrimination against the most vulnerable or hard-to-reach groups. The goal is to ensure decisions are fair, inclusive, and based on the right factors. |
| Language Models | Computing | Computer programs that help predict or generate text based on patterns they have learned from large amounts of data. For example, they suggest words when you type on a smartphone (text prediction) or help finish your sentences (auto-complete). They are also used in chatbots and virtual assistants. Unlike Large Language Models (LLMs), which can handle complex tasks and long conversations, simpler language models focus on specific tasks like fixing grammar or suggesting short responses. |
| LLMs (Large Language Models) | Computing | A large language model (LLM) is a type of artificial intelligence (AI) designed to understand, process, and generate language. ChatGPT is one of the most widely recognised examples, but LLMs can be used for a variety of tasks, including translation, question-answering, and chatbots. In healthcare research, they can analyse doctors' notes (instead of relying solely on medical codes) to uncover additional insights about a person's symptoms or life circumstances that may not be recorded in other ways. However, LLMs are not yet in general healthcare use due to safety concerns and ongoing evaluation processes. |
| WGS (Whole Genome Sequencing) | Health Research | A process that reads the entire DNA sequence of a person. It can be used to find genetic changes linked to diseases. |
| ICD-11 (World Health Organization International Statistical Classification of Diseases and Related Health Problems, 11th Revision) | Health Services and Health Data | The latest version of the World Health Organization's system for classifying diseases. It builds on ICD-10, adding more detailed coding options for better healthcare tracking. Example: ICD-11 includes codes for newly recognised conditions, such as 6C51 for "Gaming disorder," reflecting modern health challenges. It also refines older categories. For example, codes for mental health conditions now allow for more detailed descriptions. Both systems are used to track diseases and improve healthcare, but ICD-11 is more modern. |
| ICD-10 (World Health Organization International Statistical Classification of Diseases and Related Health Problems, 10th Revision) | Health Services and Health Data | A global system for diagnosing, classifying and coding diseases and health conditions. Doctors use ICD-10 codes to record patient diagnoses in medical records. Example: A doctor diagnosing depression might use the ICD-10 code F32.1 for "Moderate depressive episode." This code ensures that the diagnosis is consistent worldwide. The code E11 is used for "Type 2 diabetes mellitus." In mental health, for each disease or condition, ICD-10 specifies the symptoms and how long they must be present for a diagnosis. These codes also help healthcare systems to understand how common certain diseases are and to allocate resources like funding or research accordingly. The classification system is updated version 11 is the latest. |
| HPO (Human Phenotyping Ontology) | Health Research | A worldwide standard list of terms used to describe different human characteristics and symptoms in a consistent way. For example, it helps researchers categorise traits like "short height" or symptoms like "hearing problems" to study genetic conditions. |
| Workforce Capacity Building | DATAMIND | Activities aimed at enhancing the skills, knowledge, and capabilities of people within a workforce or those with lived experience to increase capacity in a field. To learn more, click here. |
| VELA | DATAMIND | A tool/software being developed for linking databases and extracting data for research projects. |
| Variable | Data in General | A variable is something that can change or have different values. In computing, it refers to a specific piece of information, like "date of birth," "haemoglobin level," or "diagnosis." These variables hold different data depending on the situation or individual being considered. For example, the variable "date of birth" can have different values for different people, representing their specific birth dates. Variables are used to represent different types of information in datasets. |
| User Interface (UI) | Computing | The way humans interact with a computer is known as the user interface (UI). Databases, which store information, are not very user-friendly, so Electronic Health Record (EHR) systems are designed to present information in a more understandable way for patients and clinicians. EHR systems focus on one patient at a time, making it easier for humans to navigate and enter data rather than a database which might contain information about thousands of patients. A good EHR user interface (UI) is designed to help users quickly find important information. It prominently displays alerts, such as allergies, to ensure they are noticed. It also makes it easy to enter new information. Additionally, a good EHR UI may offer "decision support," which means it provides helpful reminders or suggestions. For example, it may warn about potential interactions between two medicines before prescribing them. In summary, the EHR UI aims to present information in a clear and user-friendly manner, making it easier for humans to interact with the system, find information quickly, enter data efficiently, and receive helpful prompts when needed. |
| Unstructured Data | Data in General | Unstructured" data is a bit misleading because all data inherently has some structure. However, researchers use this term to describe data that has limited or challenging structure for analysis electronically. Examples of such unstructured data include free text, like paragraphs of written information, or images such as X-ray or scan pictures, or scanned letters. These types of data are not easily organised in a way that computers can analyse directly, making it more difficult to extract information automatically compared to structured data that follows a format or layout divided for example into categories. |
| Underserved populations | Health Services and Health Data | Underserved populations are groups or communities that face limited access to resources, services, or support due to barriers like social, economic, or systemic factors |
| UCL | Specific DATAMIND Teams or Related Services | This is a university in London, it used to stand for University College London before it was rebranded as ‘UCL' |
| Trusted Research Environment (TRE) | Processes | A secure computing environment, where data can be analysed that is too sensitive to be made public. This might be data that could uncover someone's identity, or information that's been modified to hide personal details but still carries a slight risk of being pieced together to reveal someones identity. A Trusted Research Environment (TRE) serves as an excellent example of such a safe place. TREs handle various aspects: they control what data and analysis tools are brought in, determine who's allowed entry through strict authentication and authorisation, set the boundaries for what researchers can do, and ensure that any findings don't unintentionally expose confidential information. Many TREs even offer highly secure "remote desktop" setups, enabling researchers to work from afar, and some go the extra mile by having cameras to monitor researchers. The best way to picture it is by comparing it to a secure and monitored library. Imagine a researcher going into the library to read or work on stuff, but they can't take the books away. Plus, anything they do in the library is closely watched and monitored. To sum up, a TRE provides an absolutely secure and closely monitored setting for working with private data. |
| Treatment response | Health Research | Refers to how a person reacts or responds to a specific treatment or intervention. It describes the outcome or result of the treatment and helps assess its effectiveness in addressing a particular condition or improving a person's health. |
| Text Analytics | Computing | The process of examining and understanding written information, like electronic health records or other text-based content, to find important and useful insights. It involves analysing the text to identify patterns, trends, or valuable information that can be used for various purposes, such as research or decision-making. |
| Super Research Advisory Group (SRAG) | DATAMIND | A group of diverse individuals, including service users and carers with lived experience, who are interested in data and provide valuable advice and guidance to the project. They help make important decisions and ensure the project is relevant and responsive to the needs of patients and the public. |
| Structured Query Language (SQL) | Computing | A language that helps organise and work with information stored in databases. It allows people to easily find and use data from databases, like looking up specific information or making changes to the data. |
| Structured fields | Health Services and Health Data | Sections in electronic health records where specific information is organised and categorised in a way that makes it easy to analyse. These fields are designed to store data in a standardised format, making it more accessible and consistent for healthcare professionals and researchers. |
| Structured Data | Data in General | Structured data is organised and formatted in a way that makes computer analysis easy. It is typically stored in a database as tables, where each column represents a different type of information (like numbers or words), and each cell in the table holds a single piece of data. This organisation helps with sorting, searching, and understanding the data more easily. For example, in an EHR system, there might be tables like “patient”, “referral”, “diagnosis”, and “blood test”. The “diagnosis” table might contain columns like “patient number”, “diagnosis code”, “start date”, and “end date”. Other kinds of complex structure may also be used (e.g. for genetic information). |
| Strategic Advisory Board | DATAMIND | A group of individuals who offer strategic guidance and advice to an organisation or project. They provide valuable input and recommendations to help shape the direction and decision-making processes. |
| Statistics | Analysis | Statistical analysis is a way of testing research questions (hypotheses) using data. However, it recognises that data can be "noisy" and contain all sorts of sources of variation or error, some of which are random (happen by chance) and some are not. Statistical analysis relies on mathematical theory and has been developed and used for more than a hundred years to make sense of data and draw meaningful conclusions. |
| Statistical Disclosure Control | Identifiability | To ensure data is properly anonymised, the goal is to make sure that no one can figure out the identity of specific individuals from the data, even if they use clever mathematical techniques. One way to do this is by grouping information about people into larger groups that contain at least a certain number of people, like 10 individuals. If a group is smaller than this, it's usually reported as having "less than 10 people" instead of giving the exact number. Another approach is to combine small groups to make larger ones. However, the threshold of 10 people is not a strict rule. Sometimes, even data about individuals might not reveal anyone's identity. For example, if you have a list of referral dates from a busy health service, each date corresponds to one person, but it may not disclose who those individuals are. It's important to remember that while we've been talking about protecting people's identities in health research, the same idea can be applied to other situations, like safeguarding the identification of companies through the analysis of tax data. Sometimes statistical disclosure control involves reviewing of outputs before they are released to researchers to ensure they meet criteria. Please see the ‘Five Safes' to learn more. |
| Stakeholders | Health Services and Health Data | People or groups or organisations who have a strong link, interest or involvement in a project, project area or initiative. They care about the project's outcome and are often directly affected by it. |
| SSRI | Health Services and Health Data | Serotonin Selective Reuptake Inhibitor (a class of antidepressant medication that works using this mechanism) |
| Socio-demographic factors | Characteristics of individuals or populations related to social and demographic aspects such as age, gender, ethnicity, socioeconomic status, and education level. | |
| SMI | Health Services and Health Data | Severe Mental Illness (an acronym used by primary and secondary care services, which usually refers to schizophrenia, bipolar or ‘other' psychosis diagnosis). However it is worth noting that other types of diagnosis can have a ‘severe' impact on people's lives such as anxiety or eating disorders dependant on their symptoms, how they can function in the world and context. |
| SLaM | Specific DATAMIND Teams or Related Services | South London and Maudsley NHS Foundation Trust. (a large mental health trust in South London, it pioneered the CRIS system and hosted the UCL CRIS system on its own servers). |
| Schools Health Research Network (SHRN) | DATAMIND | A research network focused on studying health-related issues in schools, particularly in Wales. It carries out a survey of all secondary school children in Wales every two years. Click here to learn about the Discoverable Schools roadbuilder and here to learn about SHRN. |
| Schools Health and Wellbeing Improvement Research Network (SHINE) | DATAMIND | A research network focused on improving health and well-being in schools, particularly in Scotland. Similarly to SHRN carries out a survey. Click here to learn about the Discoverable Schools roadbuilder and here to learn about SHRN. |
| School Network Dashboard | DATAMIND | A digital platform for schools to access data and resources for addressing mental health issues in children and young people |
| SAIL (Secure Anonymised Information Linkage) Databank | Health Services and Health Data | A secure privacy protecting database of information that researchers can use for their studies. It contains data from various sources, but personal information is removed to protect privacy. Researchers from different fields can access SAIL to collaborate and conduct research that helps patients and the general public according to the Five Safes. |
| Routinely Collected Data | Health Services and Health Data | Data collected by health, social, or school services during their everyday tasks, like doctor visits or school days. This is also known as "routinely collected data" or "real-world data." This data is not specifically gathered for research purposes. For example routinely collected health data includes details about a patient's medical history, diagnoses, treatments, medications, and other relevant health information. Researchers can use this data to analyse trends and associations and gain insights into real-world healthcare practices. |
| Roadbuilder | DATAMIND | Specific initiatives or projects within DATAMIND aimed at addressing particular challenges or areas of focus. To learn more about the 6 roadbuilders, click here. |
| RNA sequencing | Health Research | Is like taking a snapshot of the messages that our genes are sending out. It helps scientists understand which genes are active and producing proteins at a specific moment. This method provides valuable insights into how our genes work and how they affect our health and well-being. It's like eavesdropping on the genetic conversations happening inside our cells. |
| Research Approvals | Running and Overseeing Research | All research that involves NHS patients or data must get permission from an NHS Research Ethics Committee (REC). This committee includes both researchers and members of the public. REC's job is to make sure that the research is planned and conducted in a fair and ethical way and that it benefits the public. The committee looks at the research proposal to check if it meets ethical standards. They want to make sure that the rights and well-being of the patients are protected. They also want to see if the research will have a positive impact on the public by improving our understanding of health or finding better ways to provide care. By going through this approval process, the NHS makes sure that research involving their patients or data is done in a responsible and ethical manner, and that it helps the public in some way. Some types of research need approvals from other regulatory or NHS organisations as well. (There are other kinds of RECs too: for example, research in a university with healthy volunteers would usually be approved by a university REC, not an NHS REC.) |
| Relatedness | Health Research | Relatedness refers to how genetically similar or connected individuals are to each other. It's like knowing if people in a study are siblings or cousins, which can affect how their genetic information is analysed and interpreted. |
| Randomised Controlled Trials (RCTs) | Health Research | An experiment to test an intervention, such as a new medication. In a typical study, people with a condition are randomly assigned to two conditions. One group is given the new medication and the other are given a placebo (dummy) medication as the “control” condition. Having a control group is important because some changes may not be due to the medication but would have happened anyway. In a “double-blind” trial, neither the patients nor their clinicians know which is which. This is the best way to test if a treatment works. It's done this way to make sure that the results are not influenced by people's expectations or biases. By comparing the outcomes of the two groups, researchers can determine if the new treatment is effective or not. All fair tests (RCTs) follow strict rules and involve everyone in the research process. This way, everyone takes part. The process includes comprehensive quality control and rigorous quantitative analysis. |
| Quantitative Analysis | Analysis | Analysis using numbers means studying data by focusing on quantities and measurements. This involves using mathematical and statistical methods to analyse and interpret the information. Researchers look at numerical values, such as counts, percentages, averages, or correlations, to gain insights and draw conclusions from the data. This type of analysis allows for objective and quantitative assessment of trends, patterns, and relationships within the data. |
| Quality Control Complete | Processes | Is the process of carefully checking and verifying the data or samples has been finished. It's like doing a thorough inspection to make sure everything is accurate and free from errors. This step ensures that the data meets specific quality standards and is reliable for further analysis or use. It's like giving the data a green light, saying it's good to go! |
| Qualitative Analysis | Analysis | Analysis without numbers means studying information based on qualities rather than quantities. Instead of focusing on numbers and statistics, this type of analysis looks at themes. It often involves interpretation and exploration, trying to understand the meaning behind the information. One way to gather this qualitative data is through interviews with the people involved, where their perspectives and experiences are shared and analysed. This approach helps researchers gain a deeper understanding of the subject matter by delving into the rich details and personal insights provided by participants. Another example is asking a focus group about a topic, and teasing out themes in their responses (thematic analysis). |
| Public Dissemination | Processes | Sharing of project information or findings with the general public. |
| Public Benefit | Health Research | When NHS data is used for research, the patients who participate in the research don't usually get immediate benefits from it. However, the research is done with the hope that it will benefit the general public and patients in the future. The main purpose of this research is to learn more about the causes, characteristics, or effects of a disease or condition, and how to best treat it. This knowledge can then be used to help others who may have similar health problems in the future.
Example might include:
|
| Pseudonymisation | Identifiability | Data where the direct identifiers e.g. names have been removed and replaced by a research identifier (ID) or “pseudonym”, typically random codes that make no sense. Some details, like the exact date of birth, might also be changed to be less specific. For example, instead of saying "John Smith, a man born on May 5, 1980," the modified data would look like "Research ID c430c2f7a298b4e7ccd8dd763e1d85f6, male, born 1980." It may be possible and permitted for some people or organisations to re-identify or find the person, but it is impossible for others without those permissions. For example, the NHS Trust that performed the pseudonymisation could look up that c430c2f7a298b4e7ccd8dd763e1d85f6 is John Smith, but researchers analysing the data couldn't. |
| Prinicipal Investigator (PI) | Running and Overseeing Research | The researcher in charge of a study at a particular site (e.g. hospital or university). For a research study at a single site, this is the same as the chief investigator They are responsible for overseeing the study's progress, coordinating with the team members involved, and ensuring that the research is conducted according to the planned protocols. The PI plays a crucial role in managing the study. |
| Primary Care Data | Health Services and Health Data | Data collected in primary care settings, such as general practitioner (GP) clinics, which provide the first point of contact for people seeking healthcare. |
| Premature mortality gap | Health Services and Health Data | Refers to the differences in age of death and death rates across specific groups of people e.g. those with severe mental illness. It highlights a health inequality where specific populations face higher rates of death. |
| Pledges to use anonymous data for research | Special Aspects in the NHS Context | The NHS Constitution for England promises that patients' anonymous data will be used for research and to improve the care of others. |
| Phenotype Library | Health Research | A repository or collection of standardised definitions and measurements of specific characteristics or traits used in research. |
| Phenotype | Health Research | A phenotype is a set of traits or characteristics that can be observed or measured related to a particular concept or diagnosis. It includes things like physical descriptions (e.g., age, height, weight), health conditions, medications, and other measurable factors. |
| Pharma | DATAMIND | A short term for pharmaceutical, which refers to companies or organisations involved in developing and producing drugs. |
| Peer Review | Health Research | After completing research, the findings are usually sent to a scientific journal as a manuscript or paper. The journal's editor then shares the paper with other experts in the field, called peer reviewers or referees and sometimes public/lay/lived experience reviewers, e.g. BMJ (British Medical Journal). These reviewers assess the research by looking at things like the methods used and whether the conclusions are supported by the results. They may suggest changes before recommending publication, or they may advise against publishing. Peer review is considered the “gold standard” for research, but it doesn't guarantee that the research is always correct. It serves as a thorough evaluation process to ensure the quality and validity of scientific studies before they are shared publicly. |
| Patient/ Service User | Health Services and Health Data | Someone who uses health care services (such as GPs, hospitals, and clinics). |
| Patient/ Public Involvement in Research (PPI) | Health Research | "Involvement" means that research is done alongside "with" or "by" patients or members of the public (e.g. as advisors or researchers). In contrast to research “to”, “about” or “for” them. This is very different to participation in research. Patient and Public Involvement (PPI) means that people who have personal experience of a specific condition or situation are included in the planning, conduct, and application of research studies. They have a say in how the research is designed and carried out, ensuring that it meets their needs and is more relevant to their real-life experiences. By involving patients and the public, research becomes more focused on what matters to them, leading to better outcomes and benefits for everyone involved. To ensure patients and the public have a direct voice in the running and direction of DATAMIND, a Super Research Advisory Group (SRAG) was created. It is composed of people from various backgrounds, including service users and carers from across the UK, who have an interest in data. Many have connections to similar Research Advisory Groups in their local areas and to local communities interested in mental health problems. The SRAG plays a vital role in DATAMIND and contributes to all aspects of the project. |
| Patient/ Public Engagement in Research (PPE) | Health Research | Engagement" means sharing information and knowledge about research with patients and the public. This can be done through conversations with researchers, websites, written papers, or public events where the public and/or patients are invited to attend, participate and learn. The goal is to communicate research findings and insights to a wider audience. |
| Participatory Research | Health Research | "Participatory Research" can have different meanings depending on the situation. In one sense, it's when regular people take part in research. This kind of research usually involves meeting with researchers, and providing information or undergoing tests like questionnaires or brain scans. It can even include testing new treatments. In these studies, only those who agree to join are included. This is part of participatory research, and it's important that everyone knows all about it. This is where "Informed Consent" comes in. Informed consent is a big rule in participatory research. It means before someone says yes to joining a study, they need to understand everything important about it, like what the study wants to find out and what could be good or bad about it. Informed consent makes sure people decide with full knowledge. Sometimes, people who can't make decisions for themselves might be part of participatory research. But this only happens if the study is about the condition that makes it hard for them to decide, like dementia. This way, they can still be part of research that fits their situation. |
| Opt out | Health Research | When people have to specifically decide not to be part of research, or share data that already exists they will automatically be included. For example, when it comes to using their anonymous health data for research, if people don't actively opt out, their data will be included. So it's about people having to take action to be "<a href=out" and exclude themselves. |
| Opt in | Health Research | Where people choose to be “in” to participate, or not included (e.g. choosing to volunteer for research). If they don't make that active choice, they won't be included or involved in the research. So, it's all about individuals deciding to be "in" and participate, rather than being automatically included. |
| Nucleotides | Health Research | Are the small building blocks that make up our genetic code. They are like the letters in a secret code, and they come in four different types: A, T, C, and G in DNA, and A, U, C, and G in RNA. These nucleotides join together in a specific order to create the instructions that tell our bodies how to grow, develop, and function. They are the basic units of our genetic information, which is passed down from parents to children, shaping who we are. |
| NHS Act Section 251 approval | UK Law and Rules | Research is often carried out with the explicit consent of the patients involved, or by using de-identified data to protect their privacy. However, there are circumstances in England and Wales where research can be conducted using identifiable patient data without their consent. This is allowed under the General Data Protection Regulation (GDPR) and the Data Protection Act (DPA) if the research is deemed to be in the public interest. For this type of research, specific approvals are required not only from a Research Ethics Committee (REC) but also from the Confidentiality Advisory Group. Additionally, it is subject to a national opt-out, meaning that patients have the option to choose not to have their identifiable data used for research purposes. One well-known example of research conducted in this manner is the National Confidential Enquiry into Suicide and Safety in Mental Health. However, there are numerous other projects that follow similar protocols. In some cases, only basic identifiable information such as names and dates of birth is used to link data, and this information is removed before researchers see it. Even then, special approvals may still be necessary. To ensure transparency, there is a public register where approved Section 251 research projects are listed, allowing individuals to access information about ongoing studies conducted with identifiable patient data. |
| NHS Act and related confidentiality law | UK Law and Rules | In the UK, the use of health information is regulated by a number of laws and rules e.g. Data Protection Act. In England, the NHS Act 2006 is also important for this. It has been amended and clarified by other laws. Government Ministers also create additional regulations along with it.
The duty of confidentiality in health care also comes from common law (which is to say, case law coming from court cases rather than statutes decided by Parliament) and has a part in the regulation of the use of health information.
The NHS doesn't just rely on patient agreement to keep records, especially when patients can't consent.
There are different ways data is used:
|
| Natural Language Processing (NLP) | Analysis | Computer software exists to “read” free text written in a natural (human) language, and attempt to extract it as structured information. However, there are limitations because words can have different meanings, and the software cannot understand emotions or the intentions behind why certain words were chosen. Examples of NLP include, programs to find medications, drug treatment side effects, diagnoses, blood tests, recorded thoughts of suicide, “negative” symptoms of schizophrenia, and so on. NLP is difficult because grammar is complex. An NLP program to find hopelessness as a symptom of depression might need to distinguish “X is feeling hopeless” from “X used to feel hopeless but is now better”, “X's spouse is feeling hopeless”, and “X said he is hopeless at football”. NLP programs are imperfect, and need checking when they are designed in one context and then used in another, but may still be very useful. NLP is mostly used for research, but as NLP improves, it could become common in clinics and hospitals because it helps doctors understand and use patient information better. For instance, it might assist doctors in quickly finding important details in medical records, making diagnoses faster and more accurate. |
| Natural experiments | Health Research | Research studies that use real-world events or policy differences between nations or areas to understand their different impacts on populations. These studies don't involve direct intervention or manipulation by researchers. |
| National Health Service (NHS) | Health Services and Health Data | The National Health Service (NHS) refers to the publicly funded health care systems in England, Scotland, and Wales. In Northern Ireland, it is known as Health and Social Care (HSC). |
| National Data Opt-Out (NDO) | Special Aspects in the NHS Context | By default, patients are included in the system. But if you don't want your private information to be shared, you can choose to opt-out using the National Data Opt-out in England.
The NHS National Data Opt-Out allows you say 'no' to sharing your personal information for things like research without asking you first. This comes from the NHS Act Section 251.
However, if your information can't be linked to you or the NHS only uses it for their own purposes, this rule doesn't count. Sometimes, if they get special permission (Section 251 approval), they can still use information that identifies you.
The trouble is, not many people know about this choice to opt-out. Usually, patients are added automatically unless they decide not to be.
To say 'no':
|
| National Data Guardian | Special Aspects in the NHS Context | The National Data Guardian for Health and Social Care advises the UK government and NHS on the processing of health and adult social care data in England. They are independent and appointed by the Secretary of State for Health and Social Care by statute. Their job is to make sure people's confidential information is safeguarded securely and used properly. Both the Caldicott Guardian and the National Data Guardian protect patient information. The National Data Guardian oversees data use across the entire UK health sector to ensure proper use of patient info. The Caldicott Guardian focuses on data protection within individual healthcare organisations. |
| Mixed methods research | Analysis | This sort of research mixes methods. It often includes analysis of numerical data (quantitative research) and analysis of interviews with people (qualitative research) to get a clearer picture of something. |
| Missingness data | Analysis | Missingness means that some data is not available or is incomplete in a dataset. It's like having a few pieces missing from a puzzle, which can make it harder to see the whole picture. |
| Microarray (array for short) | Health Research | A DNA microarray is like a super microscope slide with thousands of tiny spots, and each spot has a specific DNA sequence or gene. It's a tool used in the lab to check the activity of many genes all at once. This helps scientists understand which genes are active and how they might be influencing things in our bodies. |
| Metadata | Data in General | Data about data! Metadata is a description of a data table, letting us know what it's about (e.g. “this table records referrals for psychological therapy”), what's in it ((e.g. whether it's a number, a date, a code with a few possible values, or free text) and what things mean (e.g. “code P means a referral from the GP, code S means a referral from a Consultant doctor”). Think of metadata as a detailed guide that helps you find and explore data, much like an index or table of contents. It gives us extra details that make the data easier to understand and use. |
| Mental Health Text Analytics Cloud (MH-TAC) | Computing | A prototype platform that uses advanced technology to analyse text files from various mental health services. It helps process and understand the information using natural language processing algorithms. The text is made anonymous or replaced with fake information to prevent identification. Strong security measures, like encryption and controlled access, are in place to ensure this protection. Regular checks are done to keep the platform secure and compliant with privacy rules. |
| Mental Health Research Framework | DATAMIND | A roadmap that guides researchers in conducting studies about mental health. It provides a structure by outlining the principles, goals, and strategies that should be followed during the research process. |
| Mental Health Data | Health Services and Health Data | Medical data relating to mental health (psychological or psychiatric) problems and health care. |
| Mental Capacity | Health Research | The ability of a person to make an informed decision. In the UK, the law sets out what this means. Research involving people whose mental capacity is impaired has to follow special rules to keep participants safe. People's ability to understand things can change based on their health and situation. When they agree to something, it's important to check if they understand because this can sometimes be tricky to figure out. That's why it's necessary to assess their understanding right when they agree. |
| Medical Research Council (MRC) | Health Research | The UK's Medical Research Council (MRC) is a government organisation that funds and supports scientists. These scientists' study medical topics to discover better ways to keep us healthy and treat illnesses. Since 1913, they've been involved in this effort, uncovering important information that supports medical professionals in caring for us. The MRC funds DATAMIND. |
| Medical Research | Health Research | A process to investigate a health-related question. Often to see if it can improve care and treatment for patients or systems in the NHS. Research is conducted in research “studies” or “projects”. |
| Machine Learning (ML) | Analysis | Machine learning is like teaching a computer to learn on its own. It can find patterns in data and make predictions about what might happen in the future based on the data. ML algorithms (which are computer programs) can work by themselves (“unsupervised”) to discover patterns, or can be trained to classify data automatically based on examples classified by a human (“supervised”). Machine learning can do impressive things like spotting breast cancer in X-ray pictures. But there are two problems. First, what is learnt in one system doesn't always work in another. Second, is that a system taught by machine learning may be like a “black box”: it might be difficult for a researcher, clinician, patient or member of the public to understand how it reached its decision, and therefore to trust its results. |
| Long-read sequencing | Health Research | Is a method used to read longer sections of a person's genetic code all at once. This technique provides more detailed information about complex parts of the genetic material, giving scientists a better understanding of the individual's genes. It's like reading a longer paragraph in a book, which helps us see the whole picture and discover more about someone's unique genetic makeup. |
| Longitudinal Population Studies (LPS) | Health Research | Ongoing studies that follow the same group of individuals over time to gain insights into their health and well-being. |
| Longitudinal Dataset | Data in General | A collection of data related to the same group of people over a long time to see how things change. This may involve asking the same questions at different ages. |
| Lived experience | Health Services and Health Data | Insights and perspectives gained from individuals who have directly experienced a particular condition e.g. depression or situation e.g. carer. |
| Linkage of data (data linkage) | Processes | Joining (linking) data from more than one source. For example, to study the relationships between mental and physical health conditions, it might be necessary to link data from NHS mental health services to primary care (GPs) or acute hospital data. To study the relationships between health conditions and education, it might be necessary to link data from health services and a government education department. Linkage may be legally complex because it involves data from more than one data controller. Linkage may be based on straightforward rules (“two records with the same NHS number are from the same person”) or based on probability (“if two records share the same forename, surname, and date of birth, they are more likely to be from the same person”). Links may be made using identifiable data (e.g. NHS number) or de-identified data (e.g. a research pseudonym). |
| Jigsaw Attack | Identifiability | A jigsaw attack is when someone tries to find out who a person is from data that was supposed to hide their identity. It's like solving a puzzle by putting together different pieces of information to figure out who the person is. For example, if there's data saying that a "57-year-old woman with anxiety" was in a bus accident, and a newspaper reported the accident and mentioned her name, someone could use both pieces of information to discover her identity and the fact that she had anxiety. Jigsaw attacks can be done by people with bad intentions who want to learn personal information about someone, or by security researchers testing how well data protection systems work. Usually, jigsaw attacks are against the law, but there are special cases where they are allowed, such as when testing privacy systems. It's surprising how even a small amount of information can sometimes be enough to identify someone. However, if the data is about groups of people rather than individuals, jigsaw attacks become much harder or even impossible, especially when dealing with larger groups. |
| Integrated Care | Health Services and Health Data | Coordination and collaboration among different healthcare providers and other settings to ensure comprehensive and seamless care for individuals e.g. child and adolescent health services and schools. |
| Informed Consent | Health Research | “Informed Consent” is when people are asked to be part of something, whether it's an official research study or not. When someone wants you to be involved in something, they should tell you everything you need to know about it—what's going on, what could go right or wrong, and what will happen to the information you share. This helps you decide if you want to join in or not, based on having all the facts. This can extend to situations where people collaborate to understand and tackle problems, even if they aren't following a strict research study format. And "Informed Consent" is still important in these situations to make sure everyone knows what they're getting into and can make their own choices. Normally, medical research studies where people take part (‘participatory research') may only involve those who consent. Informed consent here is an internationally agreed ethical principle of participatory research. “Informed” means that before deciding, the person should understand all relevant aspects of the study, including its aims and potential risks and benefits Consent might not always be necessary in non-participatory epidemiological research that uses anonymised, routinely collected data. This kind of research doesn't require direct participation from people, as researchers work with data that has already been gathered. If it's ensured that nobody can be identified from the research, consent might not be needed. It's important to know that consent can change over time. People can decide to stop participating in research whenever they want, and they won't be treated badly for it. This highlights how vital it is for researchers to keep talking with participants openly. This way, participants can freely decide what's best for them and feel like their choices matter. |
| Information Governance (IG) | UK Law and Rules | Information Governance (IG) is how an organisation takes care of its information or data. It involves strategies and processes for collecting, storing, securing, using, protecting and disposing of data safely, while also respecting privacy. IG ensures that data is managed well throughout its life cycle, following guidelines and laws. It helps organisations handle data responsibly, protect it from risks, and use it in a way that follows rules and keeps people's information safe. |
| Information Commissioner's Office (ICO) | UK Law and Rules | The UK's independent authority for data protection. The ICO oversees the application of the Data Protection Act. If you have questions about data protection or want to report a data breach, you can reach out to the ICO through:
|
| Industry Forum | DATAMIND | These are events or meetings where people from a various industries related to mental health, e.g. pharmaceutical, digital therapeutics, well-being, get together to talk about important subjects or problems that are relevant to the field. It's a way for industry representatives to share ideas, knowledge, and solutions to common issues. To learn more, click here. |
| Imputation platform | Analysis | Is like a smart tool that helps scientists guess or predict missing parts of a person's genetic code. It uses existing data and patterns to fill in the gaps and create a more complete picture of their genetic information. It's like completing a puzzle by using hints to guess what the missing pieces might look like. This helps researchers study a wider range of genetic variations and understand more about a person's unique genetic makeup. |
| Identifiable Data | Identifiability | Identifiable data is information that directly tells you who someone is. It includes things like their name, date of birth, address, NHS number, and phone number. These are direct identifiers. For example, if you have a person's name, birthdate, and NHS number, you can easily identify them. This kind of data is private and needs to be handled carefully to protect people's personal information. A fictional example: “John Smith, male, DOB 3 Jan 1948, NHS# 1234567890, diagnoses of depression and heart failure” where “John Smith, male, DOB 3 Jan 1948, NHS# 1234567890” is the identifiable data. |
| HES | Special Aspects in the NHS Context | Hospital Episode Statistics (HES) is a dataset that contains information about hospital care in England. There are similar datasets in devolved nations e.g. Patient Episode Dataset, Wales PEDW. HES provides details about various aspects of hospital care, such as patient admissions, procedures, diagnoses, and treatments. It helps researchers and healthcare professionals understand patterns, trends, and outcomes related to hospital services in the UK. By linking HES with CPRD, which is a larger and more comprehensive dataset, researchers can gain a more complete picture of patients' healthcare journeys such as from general practice to hospital admission. This linkage allows them to explore connections between hospital care and other healthcare data, enabling deeper insights into patient experiences, treatment effectiveness, and health outcomes. |
| Genotyping | Health Research | Genotyping means studying a person's DNA to find specific differences in their genes that can affect traits or health conditions. It helps scientists and doctors learn more about a person's genetic characteristics and potential risks for certain diseases. |
| Genomic Studies | Health Research | Research that investigates the molecular biology concerned with the structure, function, evolution, and mapping of genomes. A genome is an organism's complete set of DNA, including all of its genes as well as its hierarchical, three-dimensional structural. It involves studying the DNA and genetic makeup to understand how genes influence traits, diseases, and other characteristics. |
| Genome | Health Research | The genome is the entire collection of DNA, which is like a genetic blueprint, found in an organism. In humans, nearly all cells carry a full copy of the genome. This genetic information holds all the details necessary for a person's growth, development, and the traits they inherit. It's like a comprehensive set of instructions that guide how a person is built and how their body functions. |
| Genetic studies | Health Research | Research that investigates individual genes and their roles in inheritance and disease whereas genomics aims at the collective characterisation and quantification of all an organism's genes, their interrelations and influence on the organism. |
| Free Text | Data in General | Humans find it easier to write in sentences or notes than to enter information into databases in a structured format often using codes for diagnoses like depression. Patients write to clinicians and provide comments to health services. Clinicians write letters to each other and make notes in health records. This means that EHR systems often contain large quantities of text like “I met Mr Smith today. He is recently divorced. He has depression.” This is known as “free” text because the person is free to write anything, without electronic coding constraints. Free text often contains important information. It is easy for humans to understand, but much more challenging to use for research. Unlike structured data, which can be easily categorised and analysed, text requires more effort and advanced techniques to extract meaningful information. Research projects using EHRs might ignore free text and just use structured data such as a code for ‘depression'; or employ a human expert to read free text (typically after de-identification); or use more advanced technologies like natural language processing. |
| Five Safes | Processes | The Five Safes framework, created by the UK Data Service in the UK, helps researchers use private data carefully while keeping people's information safe. People around the world now see it as a good way to handle data responsibly.
Here's a simplified explanation of each of the five safes:
|
| Federation | Processes | When multiple databases from different places work together as if they were one big database, it's called a federated database. For example, researchers used the TriNetX international federated database to study how COVID-19 affected mental health. The researchers ask a question electronically, which the gets split into multiple queries. These queries are sent securely over the internet to all the different databases. (e.g. “how many people in your database had COVID-19, and of them, how many developed depression in the next three months?”). |
| FAIR Data | Data in General |
|
| European Union (EU) General Data Protection Regulation (GDPR) | UK Law and Rules | The 2016 GDPR set out the EU framework for the handling of data relating to identifiable living people. Among many other things, it sets out a variety of legal bases for using personal data, such as “the data subject has given consent”, “a task... in the public interest”, or for “scientific... research”. The UK DPA was framed in its terms and set out UK-specific aspects. When the UK left the EU in 2020, the GDPR remained in UK law as the “frozen GDPR” or “UK GDPR”. |
| Ethical approvals | Running and Overseeing Research | Ethical approvals are like getting the green light from a group of experts who make sure that research is done in a proper and respectful way. They ensure that participants' rights are protected and everything is conducted responsibly. It's like having a permission slip before starting the research to ensure everything is fair and safe. |
| Equity audits | DATAMIND | The aim of these assessments is to guarantee equal opportunities for everyone to take part in the trials. They examine the fairness and inclusivity of clinical trials, with a focus on participant representation (including underserved groups and all genders) and access. They are not universally mandatory for all trials. Whether these assessments are obligatory depends on the specific regulations in place. It's recommended to refer to the relevant guidelines to determine if these assessments are required for the trials being conducted. |
| Equity audit tool | DATAMIND | A checklist or tool that helps make sure things are fair and equal for everyone. It looks at systems, processes, or research studies to see if there are any differences or imbalances between different groups. It helps identify and address any unfairness or inequalities, making sure everyone is treated fairly and included. |
| Epidemiological or Observational Research | Health Research | Research in which data about people is analysed. Although this might be participatory research (the researchers meet people and collect data from them specifically for the study), this kind of research often uses routinely collected data from large numbers of people (i.e. from contacts with GPs). Using information from a very large number of people often makes the research better able to find answers. However, conclusions from routinely collected data are tentative, because “correlation does not imply causation”. If event A is associated (correlated) with event B, is that because A causes B, because B causes A, because X causes both A and B, or was it a chance finding? Strong conclusions may require randomised controlled trials. |
| Electronic Health Record (EHR) | Health Services and Health Data | A person's health records that are held digitally on a computer (as opposed to on paper). Also known as an electronic patient record (EPR). |
| E-cohorts | Health Research | E-cohorts are well defined groups created based on electronic data which enable analysis and comparison. |
| Early Career Researchers (ECRs) | Health Research | People who are in the early stages of their research careers, typically within a few years of completing their doctoral degree or equivalent. |
| Digitally enhanced trials | Health Research | Clinical studies that use digital technologies to improve the way trials are conducted. These technologies can include apps, wearable devices, and online platforms that make it easier to recruit participants, collect data, and deliver interventions. By incorporating digital tools, trials become more efficient and accessible, leading to better healthcare outcomes. |
| De-identification | Identifiability | De-identified data is where personal details (those which can directly identify a person such as their name and address) have been removed. This is done by replacing or removing these direct identifiers. Where they are replaced by a research identifier (ID) or “pseudonym” this is called pseudonymisation. Both structured data and text can be de-identified. The aim is to ensure data used for analysis or research does not reveal who people are. |
| Database | Data in General | Databases mainly consist of tables that hold organised information. These tables often connect with each other, forming "relationships" between records. These connections are typical in "relational" databases, where one record refers to another, even in different tables. Each table is like a grid with rows and columns, focusing on something of interest, such as clinic referrals. Columns represent simple details about the table, like "referral number" or "referral date." Each row, known as a "record," corresponds to a single instance, like a unique referral. In the grid, where rows and columns meet, you find a "value" (also called a "field" or "cell"), which holds a single piece of information, like "2023-01-01." Sometimes, values can be missing, appearing as blank or "null." |
| Data utilisation | Data in General | Making the best use of available data to learn important things, make smart choices, and take the right actions based on the information gathered |
| Data Users | Data in General | People or organisations who access and use collected data for research or other purposes |
| Data Transfer Agreement | UK Law and Rules | When a person or organisation that has control over data wants to share that data with another organisation, they make an agreement or contract. This agreement outlines the terms and conditions for how the data can be transferred and used by the other organisation. The agreement ensures that both parties understand and agree on how the data should be handled. So a Data Transfer Agreement is an agreement or contract between a data controller and another organisation (such as a data processor), governing the transfer of data. |
| Data Subject | UK Law and Rules | A person whose personal data is being held by a data controller. |
| Data Security Standards | Computing | There are rules, regulations, standards and guidelines for keeping data secure. In the NHS (National Health Service), they use a tool called the Data Security and Protection Toolkit to evaluate and improve data security. Private companies and data centres also use similar but not exactly the same ones used in the NHS often based on international standards. |
| Data Science Approaches | Processes | These are different ways of using technology and methods to look at data and find useful information from it. Data scientists use special techniques to analyse and understand data, so they can solve problems or find answers to questions. They use tools and methods to make sense of the data and discover important insights that can help with decision-making or problem-solving. |
| Data Science | Data in General | Data science is a field of research that focuses on learning from data. It involves different areas of study, like storing, organising and processing data (data management, computer science), and analysing data to find useful patterns (computer science, statistics).It also requires thinking about the specific problem (e.g. a particular disease or condition of interest); after all, there is no science without data. All these different parts mean data science is often an interdisciplinary field with lots of people from different scientific backgrounds working together (like clinicians and computer scientists). Data science helps us gain knowledge and insights from the data we have. |
| Data Protection Officer | UK Law and Rules | Where data controllers/processors are public bodies or organisations handling personal data on a large scale, they must (under the GDPR) appoint a data protection officer to advise them on data protection and monitor compliance. Data protection officers are listed on the public register held by the Information Commissioner's Office (ICO). |
| Data Protection Impact Assessment | UK Law and Rules | Before your personal information is used or processed, the possible risks to you as the ‘data subject' need to be assessed. This assessment is your Data Protection Impact Assessment. It includes the measures planned to manage those risks and protect your personal information. It's like a safety check to make sure your information stays safe and secure. It's also called a privacy impact assessment. |
| Data Protection Act (DPA) | UK Law and Rules | The Data Protection Act 2018 is the UK's principal law governing the handling of data relating to identifiable living people (“personal data”). It implemented UK-specific aspects of the GDPR and superseded previous UK legislation. The Act primarily guides organisations in handling data, but it also grants individuals rights to protect their own data. |
| Data Processor | UK Law and Rules | Whereas a data controller decides what is done with data, data processors do what they're told (and only what they're told) by the controller, with the controller's data. For example, it would be typical that an NHS Trust pays a computing company to run its e-mail service or to run an EHR system. In this situation, the NHS Trust is likely to be the data controller, and the computing company the data processor. The data processor isn't allowed to use the controller's data for other purposes, e.g. sending out advertising to individuals. |
| Data Mining | Data in General | Data mining is like searching for patterns in data, especially when there's a lot of it. Instead of starting with a question (or ‘hypothesis testing', you explore the data to find interesting things you didn't expect. Sometimes, this involves using machine learning techniques. However, one risk of data mining is of finding patterns that seem important but are actually just random or because your data is flawed. So, it's important to be careful and make sure the patterns you discover are truly meaningful. |
| Data Literacy | Data in General | The ability to understand, analyse, interpret, and critically evaluate data and data related studies. |
| Data Governance | Processes | Policies, procedures, and regulations that govern the collection, storage, access, and use of data to ensure privacy, security, and ethical considerations are addressed. |
| Data Discovery | Processes | The process of identifying and accessing relevant data sources for research or analysis |
| Data Curation | Data in General | This is like being a caretaker for data, similar to a museum curator. It is basically looking after data for other people to work with it. This can involve putting data together, quality control (finding and removing errors or invalid data), describing it well so that other researchers can understand it (providing metadata or a catalogue), or mapping it to a standard “vocabulary” (e.g. if two databases record problems using different coding systems, can those be mapped to each other?). The overall goal is to maintain and manage the data for easy use by others. |
| Data Controller | UK Law and Rules | A data controller is a person or organisation who decides how personal data, which is information about identifiable individuals, is used or handled. Examples of data controllers include NHS organisations like Trusts and GP surgeries. On the other hand, a data processor is a person or organisation that processes personal data on behalf of the data controller. In the UK, all organisations that handle personal data, with very few exceptions, must be registered with the ICO (Information Commissioner's Office), and this registration information is publicly available. Data controllers have a legal responsibility and can be held accountable if there's a problem with how personal data is handled. This includes breaches or misuse of data. They must take measures to prevent issues, promptly report breaches to the relevant authorities, and can face fines if they don't meet their obligations. |
| Data | Data in General | Data means information. It can be numbers, text, images, videos, sound recordings, or any other type of information that can be collected, stored and analysed by computers or humans. Data is a very broad term. In health research we usually mean information (data) about a person which is stored electronically (on-line). |
| Core Mental Health Dataset (CMHDS) | DATAMIND | A tool used to collect information about mental health during physical health clinical trials. It helps researchers gather important data specifically related to mental health and well-being alongside physical health information. This tool is part of the work done by DATAMIND. |
| Core Activities | DATAMIND | The main things a project (like DATAMIND) focuses on to be successful. It's the key areas of expertise and knowledge that the project specialises in to achieve its goals. |
| Consent and Informed Consent | Processes | Understanding how consent (or the lack of it) works for sharing healthcare data in the UK is essential. There are different rules depending on how easy it is to figure out who the data is about and where you are. In the UK, there's a rule that currently says you don't need to give informed consent if the data collected regularly is made fully anonymous. This means that your personal details are taken out, and no one can link the data back to you. However, it's a good question to ask whether all the data labeled as "anonymous" is truly untraceable. But, when it's about sharing personal healthcare data that can still identify you, it gets more complicated. The level of how easy it is to tell who you are and where you're located matters. Some places might want your agreement before they share your data, while others might not. It's important to note that the "National Data Opt-Out" is available in England. It lets you decide whether your data can be shared, even if you said yes before. This opt-out is like a way to say "no" to certain kinds of sharing. Remember, even though consent might not be explicitly requested in every situation, the choice not to ask for it is part of the current system. Informed Consent and Choices: Consent and informed consent are both about agreeing to something after understanding it fully. Regular "consent" involves knowing all the details and agreeing, just like when you give permission for the use of personal data in research after understanding the risks and benefits. "Informed consent" is a term we use when we want to emphasise that understanding is crucial before agreeing. In most cases, whether it's sharing personal data or participating in studies, consent should always be informed. It's important to know that consent can change over time. People can decide to stop participating in research whenever they want, and this will not affect their healthcare treatment. This highlights how vital it is for researchers to keep talking with participants openly. This way, participants can freely decide what's best for them and feel like their choices matter. |
| Confidential Advisory Group (CAG) | Special Aspects in the NHS Context | The Confidential Advisory Group (CAG) is a multi-disciplinary group within the NHS Health Research Authority. It plays a role in England and Wales when researchers want access to confidential patient information that's not fully anonymised and consent isn't possible. When this happens approval from the CAG is required. The group advises and operates on behalf of the Secretary of State for Health and Social Care. |
| Code Lists | Data in General | A collection of specific codes that are used in healthcare to represent different things, such as medical diagnoses, treatments, or procedures. These codes are standardised and help healthcare professionals classify and identify specific information in a consistent and uniform manner. Code lists make it easier to communicate and exchange information accurately within the healthcare field. |
| Cloud storage | Computing | Cloud storage is like a virtual locker on the internet where you can keep your files, photos, and documents. Instead of storing everything on your device, you upload them to this online space. Think of streaming a movie online instead of downloading it, sharing photos on social media, storing files in Google Drive or iCloud, sending emails through services like Gmail, and collaborating on documents in real time. All these activities involve using cloud storage, where you access and manage content over the internet, without needing to keep everything on your device. |
| Cloud computing | Computing | Cloud computing means another company handles things like computers, storage, software, and more, over the internet. Big names like Amazon, Google, and Microsoft do this. They store your data and let you analyse it using their powerful machines (lots of computer processors and memory). The provider typically looks after things like physical security (preventing break-ins), electronic security (only permitting access by authorised users and preventing hacking over the network), and ‘resilience ‘(e.g. keeping regular backups, having devices for when one breaks, having batteries or generators for power cuts, and maybe having other data centres in case of disasters). Many cloud providers allow the customer to choose the physical location of the data centre (e.g. Cardiff versus California), which may be important for compliance with relevant data protection laws. Cloud computing is distinguished from computing “on premises”, i.e. physical computers that an organisation (such as an NHS Trust) owns and looks after itself. |
| Clinician | Health Services and Health Data | A member of staff in a health care service (such as a nurse, doctor, or psychologist) who delivers care to patients/service users. |
| Clinical/ Medical/ Health Data or Healthcare data | Health Services and Health Data | A person's information about their health or dat to day health care.
Healthcare data is the information collected about a person's health and medical care. This information is collected as people see healthcare professionals, have tests and treatments as part of their care. It is stored in electronic health records (EHRs) used by the NHS. There are different types of healthcare data:
|
| Clinical trial data | Health Research | Information collected during research studies that evaluate the safety and effectiveness of medical treatments or interventions. |
| Clinical Trial | Health Research | A trial refers to a research study conducted to test a new treatment, like a medicine or talking therapy. When it comes to testing medicines, clinical trials are known as Clinical Trials of Investigational Medicinal Products (CTIMPs), and they have additional special rules and regulations that need to be followed. These rules ensure the safety and effectiveness of the new treatment being tested before it can be made available to the general public and the safety of the people participating in the trials. |
| Clinical Research Network (CRN) | Health Research | A network that helps coordinate and support research studies in the National Health Service. The CRN's primary goal is to enhance the quality and quantity of clinical research conducted across the NHS by providing the infrastructure, expertise, and resources needed to carry out research studies effectively. The CRN helps doctors and scientists work together on research projects. They find patients who want to be part of these projects and make sure the research is done correctly. By gathering this information, they can learn more about how different treatments and medicines work. They can find out what works best for patients and help doctors make better decisions about how to treat people. This teamwork and data collection also lead to new ideas for treatments and medicines in the future. |
| Clinical Record Interactive Search (CRIS) | Specific DATAMIND Teams or Related Services | (1) An anonymous version of electronic clinical records in the South London and Maudsley NHS Trust, used for research. (2) Specific software used to de-identify electronic records, also used elsewhere. |
| Clinical Practice Research Datalink (CPRD) | Special Aspects in the NHS Context | A research database in the UK that stores anonymous patient records from various general practices. It doesn't keep all the detailed written notes from patient records. Instead, it gathers important facts like diagnoses, prescriptions, tests, and basic information about patients. This way, it's easier for researchers to study health trends while protecting patient privacy. It helps researchers study different medical conditions, treatments, and drug safety by providing access to large scale patient data. The primary care data has also been linked to data in hospitals. www.cprd.com/ |
| Children and Young People (CYP) | Health Services and Health Data | Refers to individuals in the age range from infancy to young adulthood. Usually refers to those aged from 10 - 24 years. |
| Chief Investigator (CI) | Running and Overseeing Research | The investigator (researcher) with overall responsibility for a research study, and the person who seeks ethical approvals. |
| Census | Data in General | A large survey that happens every 10 years in the UK. It asks people about things like their age, gender, and background. This information, collected from all over the country, helps with things like local service planning and making important decisions. The data is made anonymous before being used to understand the population better. |
| Caldicott Guardian | Special Aspects in the NHS Context | In the NHS, the Caldicott Guardian is a senior professional who safeguards patient confidentiality and privacy. They are responsible for protecting patient information within NHS organisations, including how it is used, following the guidelines led by Dame Fiona Caldicott, the first National Data Guardian. Both the Caldicott Guardian and the National Data Guardian protect patient information. The National Data Guardian oversees data use across the entire UK health sector to ensure proper use of patient info. The Caldicott Guardian focuses on data protection within individual healthcare groups. |
| C&I | Specific DATAMIND Teams or Related Services | Camden and Islington NHS Foundation Trust (a secondary care, mental health Trust in North London) |
| BMI | Health Services and Health Data | Body Mass Index is a measure which takes account of height and weight and charts "normal range" on a graph. It is not very sophisticated but easy to measure. |
| Big Data | Data in General | Big Data means working with large amounts of information. The definition of "big" depends on the context. It can refer to data from a huge number of people, like health records from millions of individuals. It can also refer to data that requires a lot of storage space, such as DNA sequences, MRI scan images, or activity data from mobile phones. The term "big data" became popular in the early 2000s and has been associated with over 25,000 publications in the life sciences as of March 2023. |
| Best Practices | Processes | Best practice is a standard or set of guidelines that is known to produce good outcomes if followed. They may be based on different levels of research evidence and/ or collective experience. |
| BAME | Other Terms | Black and Minority Ethnic is a general term for people with ethnic minority backgrounds. There has been debate about whether this term is useful or not. As a result there has been a move away from using it, including a directive from central government Equality Hub. Terms that are currently in use include ethnic minority, minority ethnic, and minoritised ethnic. |
| Artificial Intelligence (AI) | Computing | Artificial Intelligence (AI) is a branch of science that aims to create technology that may perform tasks and make decisions in a way that resembles human intelligence.
Progress and Gap:
AI has advanced from rule-based systems to complex algorithms like deep learning. However, it lacks common sense, true understanding, and emotions, unlike human intelligence. Exaggerated expectations have led to misconceptions about AI's capabilities.
Potential pros of AI:
|
| Anonymised results | Identifiability | Anonymised results are those that don't reveal any personal details and can be shared publicly, like in scientific journals. For example, a statement like "We studied 1000 people with depression, and 42% had tried cognitive-behavioural therapy" is considered anonymised because it doesn't provide any specific information that could identify the individuals involved. |
| Anonymisation | Identifiability | Anonymisation makes data anonymous by removing anything that could identify people. Think about a database with blood test results, diagnoses, and ages, but no personal details. It's like making the data a secret puzzle. No one knows who it's about. This keeps the data private so no one can recognise individuals. Anonymisation happens by changing or taking out personal information, or by using special software to hide private details. Yet, researchers can still use this data for answers without knowing who's who. This helps researchers learn from data while keeping it private. |
| Algorithms | Computing | An algorithm is like a recipe or set of rules that tells a computer how to work with the data. It helps the computer process and understand the information by following a series of steps. Algorithms can do things like organising data, searching for specific pieces of information, or making calculations. |
| Standardisation | Analysis | Standardisation is like having a common set of rules. In data or research, it means using the same practices or criteria to make things consistent and comparable. It helps ensure reliability and makes it easier to compare information. |
| Retrospective harmonisation | Health Research | Organising data from different studies to work together after the data has been collected. It involves making information fit seamlessly, even if it wasn't collected in the same way initially. This helps researchers analyse the combined data. |
| Rarer Outcomes | Health Services and Health Data | Life or health outcomes that are uncommon. Large-scale, diverse and/or linked data can be used to capture and study these types of outcomes. |
| Quantitative data | Data in General | Quantitative data means information that we measure or count using numbers. It's about things like height, weight, temperature, or counting how many people are in a group. Researchers use this type of data to find patterns and make predictions by looking at the numerical information. |
| Qualitative data | Data in General | Qualitative data is information that is not in numerical form. It includes detailed descriptions, often about people's experiences, opinions, or behaviours. This type of data is collected through methods like interviews, observations, or surveys with open-ended questions when you cannot just say yes or no. It helps to understand the 'why' and 'how' of certain behaviours or phenomena, giving insights that numbers alone can't provide. Examples of qualitative data might be someone's views about a new product, stories from their childhood, or opinions about a social issue. |
| Prospective Harmonisation | Health Research | Planning ahead to make sure data from different studies can work together easily. It involves setting up a common way to collect and organise information right from the start. This makes it easier for researchers to combine and analyse the data later on. |
| Outcomes of research: | Health Research | An outcome is the way something turns out, or a result or consequence. The outcomes of research include its results (what a study found out). They might also include the impact of those results: for example, successful research might change the way a condition is normally treated, for the better. (See also outcome measures) |
| Outcome measures | Health Research | An outcome is the way something turns out, or a result or consequence. Outcome measures are the important consequences studied in research. For example, when studying depression, researchers might see if a treatment makes symptoms better or worse, affects the amount of time people take off work, or alters their quality of life. (See also outcomes of research.) |
| Mental health measure | Health Research | This refers to a question or a series of questions designed to identify and assess mental health conditions or symptoms. These measures help in understanding a person's mental well-being, tracking changes over time, and can aid in diagnosis and treatment planning |
| Longitudinal (or Follow-up) Study | Health Research | A type of research study where participants are followed and observed over a long period. As the study goes on, information is collected at different time points. This data helps in understanding how certain things change or develop over time. For instance, a study could follow students from when they start school to understand how their grades and friendships change as they grow up, and how this may relate to their mental health. |
| Linked cohort study | Health Research | A linked cohort study is when data about a group of people is connected from different sources, like medical or census records, to follow them over time. For instance, the Social and Economic Predictors of Severe Mental Disorders Study (SEP-MD) links UK Census data to clinical records and death registrations. |
| Household panel | Health Research | A household panel is a study where a group of households is regularly checked on and asked questions over time. Researchers do this to learn about how these families live, how things change for them, and about their habits. They might ask about things like how much money the family makes, what they spend it on, or how their lifestyle changes. This helps to understand trends and changes in people's lives over a long period. |
| Equivalence | Analysis | Equivalence means things are the same or equal. In data or studies, it ensures that different measurements or datasets can be compared or used interchangeably because they have a similar meaning. |
| Epidemiological Study | Health Research | A type of research study that looks at how diseases or health events vary, and what factors influence them in a population. These studies help us understand (and maybe therefore improve) health problems in communities. |
| Demographics | Data in General | Facts and figures that tell us about a group of people. This includes things like their age, gender, ethnicity, education, and income. Knowing this information is important for studying and understanding different populations. |
| Data Harmonisation | Health Research | Data harmonisation is like organising different puzzle pieces, so they fit together. It's about making sure data from different studies can be compared or used together easily by standardising and aligning them. This could be by asking some of the same questions in every study. This helps researchers combine information from various places to get a more well-rounded picture. |
| Cross-study Research | Health Research | Research that involves analysing and comparing data from different research projects (studies) to understand things more better in larger or different populations. This type of research can help us identify patterns that might not be obvious in a single study. |
| Concordance | Analysis | Concordance is like checking if two things match or agree. If they do, there's high concordance; if not (if there are differences) there is low concordance. It helps check data consistency when comparing or combining information. |
| Cohort Study | Health Research | A type of research where a group of people with something in common (like birth year, similar health conditions or where they live) are followed over time, to see how various factors may affect their health or what happens to them. This approach helps researchers understand what might affect people's lives and how past experiences can have an impact later on. |
| Cohort | Health Research | A group of people who share something in common, like being born in the same year or having had a similar experience. |
| Biomarkers | Health Services and Health Data | Biomarkers are signals in the body that reveal information about our health. They can be things like proteins, genes, or measurements like blood pressure. Scientists use biomarkers to understand how our body is functioning, track health conditions, and evaluate the effectiveness of treatments. For instance, checking cholesterol levels is a common way to get insights into heart health. |
| Baseline Measurements | Health Research | The information that is collected from a group at the beginning of a study. This information is sometimes used to divide the population into different groups for analysis. |
| Accelerated cohort study | Health Research | Unlike cohort studies that follow one group of people of the same age over time, these studies track several groups, each starting at different ages. This way, researchers can learn about a wide age range faster than just watching one group grow older. However, a downside is that not all information will be available at every age in each group. |